SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-085194
Filing Date
2023-11-09
Accepted
2023-11-09 16:01:29
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_longeveron.htm   iXBRL 10-Q 1026194
2 CERTIFICATION f10q0923ex31-1_longeveron.htm EX-31.1 9394
3 CERTIFICATION f10q0923ex31-2_longeveron.htm EX-31.2 9475
4 CERTIFICATION f10q0923ex32-1_longeveron.htm EX-32.1 5850
10 GRAPHIC image_001.jpg GRAPHIC 1573
11 GRAPHIC image_002.jpg GRAPHIC 1609
12 GRAPHIC image_003.jpg GRAPHIC 1771
  Complete submission text file 0001213900-23-085194.txt   5221237

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20230930.xsd EX-101.SCH 43131
6 XBRL CALCULATION FILE lgvn-20230930_cal.xml EX-101.CAL 32313
7 XBRL DEFINITION FILE lgvn-20230930_def.xml EX-101.DEF 250538
8 XBRL LABEL FILE lgvn-20230930_lab.xml EX-101.LAB 461924
9 XBRL PRESENTATION FILE lgvn-20230930_pre.xml EX-101.PRE 264531
63 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_longeveron_htm.xml XML 626951
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 231392150
SIC: 2834 Pharmaceutical Preparations